Taro Pharmaceuticals U.S.A., Inc. is recalling 7,632 tubes of Clobetasol Propionate Cream USP, 0.05%, because the bulk ingredient used to manufacture the product did not meet consistency and uniformity standards. This prescription topical medication is used for skin conditions and was sold in 15 g and 45 g tubes. Because the medication may not be evenly distributed throughout the cream, patients may receive a dose that is either too high or too low, potentially affecting the treatment's effectiveness or safety. Consumers should contact their healthcare provider or pharmacist to discuss alternatives and how to return the product.
The cream failed content uniformity testing, meaning the active ingredient may not be distributed evenly throughout the tube. This could lead to inconsistent dosing where some applications have too much medication and others have too little, potentially causing skin irritation or failing to treat the underlying condition effectively.
Manufacturer refund through pharmacy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.